IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 144 filers reported holding IMMUNOVANT INC in Q1 2023. The put-call ratio across all filers is 0.21 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $21,558,900 | -67.1% | 1,390,000 | -62.4% | 0.40% | -69.4% |
| Q4 2022 | $65,563,530 | +118.7% | 3,693,720 | -31.2% | 1.29% | +119.2% |
| Q3 2022 | $29,979,000 | +43.1% | 5,372,512 | 0.0% | 0.59% | +31.7% |
| Q2 2022 | $20,953,000 | -29.2% | 5,372,512 | 0.0% | 0.45% | -3.4% |
| Q1 2022 | $29,603,000 | -29.8% | 5,372,512 | +8.5% | 0.46% | -13.9% |
| Q4 2021 | $42,174,000 | -2.0% | 4,950,000 | 0.0% | 0.54% | -4.9% |
| Q3 2021 | $43,016,000 | +20.7% | 4,950,000 | +46.8% | 0.57% | +18.4% |
| Q2 2021 | $35,631,000 | -10.2% | 3,370,994 | +36.3% | 0.48% | -18.5% |
| Q1 2021 | $39,667,000 | -7.9% | 2,473,000 | +165.3% | 0.59% | -10.9% |
| Q4 2020 | $43,049,000 | +31.3% | 932,000 | 0.0% | 0.66% | +2.8% |
| Q3 2020 | $32,797,000 | +115.2% | 932,000 | +48.9% | 0.64% | +94.0% |
| Q2 2020 | $15,242,000 | – | 625,950 | – | 0.33% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 1,818,371 | $69,807,263 | 24.57% |
| Alpine Global Management, LLC | 1,252,474 | $48,082,477 | 12.15% |
| Logos Global Management LP | 1,600,000 | $61,424,000 | 8.20% |
| Octagon Capital Advisors LP | 1,000,000 | $38,390,000 | 5.90% |
| Perceptive Advisors | 3,814,691 | $146,445,987 | 4.88% |
| COMMODORE CAPITAL LP | 1,000,000 | $38,390,000 | 4.49% |
| Deep Track Capital, LP | 2,797,955 | $107,413,492 | 4.15% |
| Fairmount Funds Management LLC | 750,000 | $28,792,500 | 3.46% |
| Ikarian Capital, LLC | 7,230 | $27,755,970 | 3.34% |
| ACUTA CAPITAL PARTNERS, LLC | 129,000 | $4,952,310 | 3.32% |